Thromboprophylaxis in patients undergoing total hip replacement

Hospital Medicine

Volumn 64, Issue 5, 2003, Pages 281-287

  Brenkel, I J ^a   Cook, R E ^a  

^a QUEEN MARGARET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; DEXTRAN; ENOXAPARIN; HEPARIN; HYDROXYCHLOROQUINE; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; TINZAPARIN; WARFARIN; FIBRINOLYTIC AGENT;

DEEP VEIN THROMBOSIS; HEALTH SURVEY; HUMAN; LOW DRUG DOSE; ORTHOPEDICS; PROPHYLAXIS; REVIEW; SURGEON; TOTAL HIP PROSTHESIS; UNITED KINGDOM; VENOUS THROMBOEMBOLISM; BANDAGE; HIP ARTHROPLASTY; THROMBOEMBOLISM; VEIN THROMBOSIS;

ARTHROPLASTY, REPLACEMENT, HIP; ASPIRIN; BANDAGES; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0038544277     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2003.64.5.1760     Document Type: Review

References (43)

1. Bauer KA, Eriksson BI, Lassen MR, Turpie AG (2001) Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 345: 1305-10
2. Best AJ, Williams S, Croszier A et al (2000) Graded compression stockings in elective orthopaedic surgery. An assessment of the in vivo performance of commercially available stockings in patients having a hip and knee replacement. J Bone Joint Surg 82-B: 116-8
3. Cohen AT, Bailey CS, Aliknan R, Cooper DJ (2001a) Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty - a meta-analysis. Thromb Haemost 85: 940-1
4. Cohen A, Brenkel IJ, Colerige-Smith E, Skinner J, Warick D, Phillips C (2001b) A multi-centre, randomised, open-label, parallel group, comparative study of the efficacy and safety of once daily fondaparinux 2.5mg versus fondaparinux 2.5 mg plus graduated compression stockings for the prevention of venous thromboembolism in patients undergoing elective or emergency hip surgery. British Orthopaedic Association symposium, Birmingham: 13 September
5. Colwell CW, Spiro TE, Trowbridge AA et al (1994) Use of Enoxoparin, a low molecular-weight heparin for the prevention of deep venous thrombosis after elective hip replacement. J Bone Joint Surg (Am) 76-A: 3-14
6. Colwell CW, Jolla LA, Collis DK et al (1999) Comparison of Enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip replacement. J Bone Joint Surg 81-A: 932-40
7. Dahl OE (2000) Continuing out of hospital; prophylaxis following major orthopaedic surgery: What now? Haemostasis 30(suppl): 95-100
8. Eikelboom JW, Quinian DJ, Douketis JD (2001) Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomized trials. Lancet 358: 9-15
9. Eriksson BI, Jorgenson PW, Kalebo P et al (1997) A comparison of recombinant hirudin with a low molecular weight heparin to prevent thrombo-embolic complications after total hip replacement. N Engl J Med 337: 1329-35
10. Eriksson BI, Bauer KA, Lassen MR, Turpie AG (2001) Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip fracture surgery. N Engl J Med 345: 1298-304
11. Eriksson BI, Berquest D, Kalebo P et al (2002) Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip replacement: the METHRO II randomized trial. Lancet 360: 1441-7
12. Fender D, Harper WM, Thompson JR, Gregg PJ (1997) Mortality and fatal pulmonary embolism after primary total hip replacement. J Bone Joint Surg 79-B: 896-9
13. Fordyce MJF, Ling RSM (1992) A venous foot pump reduces thrombosis after total hip replacement. J Bone Joint Surg (Br) 74-B: 45-9
14. Francis CW, Pelligrini VD Jr, Marder VJ et al (1992) Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA 267: 2911-5
15. Francis RM, Brenkel IJ (1997) Survey on the use of thromboprophylaxis for routine hip replacements by British orthopaedic surgeons. Br J Hosp Med 57: 427-31
16. Freeman KB, Brookenthal KR, Fitzgerald RH et al (2000) A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg 82-A: 929-38
17. Gardner AMN, Fox RH (1983) The venous pump of the human foot: preliminary report. Bristol Med Chir J 98: 109-14
18. Geerts WH, Heit JA, Clagett GP et al (2001) Prevention of venous thromboembolism. Chest 119: 132S-175S
19. German Hip Arthroplasty Trial (GHAT) Group (1992) Prevention of deep vein thrombosis with low-molecular-weight-heparin in patients undergoing total hip replacement. A randomised trial. Arch Orthop Trauma Surg 63: 133-43
20. Gross M, Anderson DR, Nagpal S, O'Brien B (1999) Venous thromboembolism prophylaxis after total hip or knee arthroplasty: a survey of Canadian orthopaedic surgeons. Can J Surg 42: 457-61
21. Hooker JA, Lachiewicz PF, Kelley SS (1999) Efficiency of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision hip replacement. J Bone Joint Surg 81: 690-6
22. Hui AC, Heras-Palou C, Dunn I, Triffitt PD, Crozier A, Imeson J, Gregg PJ (1996) Graded compression stocking for prevention of deep-vein thrombosis after hip and knee replacement. J Bone Joint Surg 78-B: 550-4
23. Hull RD, Pineo GF, Stein PD et al (2001) Timing of initial administration of low molecular weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty. Arch Intern Med 161: 1952-60
24. Imperiale TF, Speroff T (1994) A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 271: 1780-5
25. Lassen MR, Borris LC, Christiansen HM et al (1991) Prevention of thromboembolism in 190 hip arthroplasties: comparison of LMW heparin and placebo. Acta Orthop Scand 62: 33-8
26. Lassen MR, Bauer KA, Eriksson BI, Turpie AG (2002) European Pentasaccharide Elective Surgery Study (EPH-ESUS). Post operative Fondaparinux versus preoperative Enoxaparin for the prevention of venous thromboembolism in elective hip replacement A randomized double blind comparison. Lancet 359: 1715-20
27. McGrath D, Dennyson WG, Rolland M (1996) Death rate from pulmonary embolism following joint replacement surgery. J R Coll Surg Ed 41: 265-6
28. Mesko JW, Brand RA, Iora R et al (2001) Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients. A survey of AAHKS members. J Arthroplasty 16: 697-88
29. Murray DW, Britton AR, Bulstode CJK (1996) Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg 78-B: 863-70
30. Paiement GD, Wesinger SJ, Waltman AC et al (1987) Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement. J Arthroplasty 2: 23-6
31. Palmer AJ, Koppenhagen K, Kirchof B et al (1997) Efficiency and safety of low molecular weight heparin, unfractionated heparin and warfarin for thromboembolism prophylaxis in orthopaedic surgery. A meta-analysis of randomised clinical trial. Haemostasis 27: 75-84
32. Pulmonary Embolism Prevention Trial Collaborative Group (2000) Prevention of fatal post operative pulmonary embolism and deep vein thrombosis with low dose aspirin; Pulmonary Embolism Prevention (PEP) trial. Lancet 355: 1295-302
33. Samama CM, Clergue F, Barre J, Montefiore A, Ill P, Samii K (1997) Low molecular weight heparin associated with spinal anaesthesia and gradual compression stockings in total hip replacement surgery. Arar Study Group. Br J Anaesth 78(6): 660-5
34. Sarmiento A, Goswami AD (1999) Thrombo-embolic prophylaxis with the use of aspirin, exercise and graded elastic stockings or intermittent compression devices in patients managed with a total hip replacement. J Bone Joint Surg 81-A: 339-46
35. Stannard JP, Harris RM, Bucknell LA et al (1996) Prophylaxis of deep of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. Am J Orthop 25: 127-34
36. The Danish Enoxaparin Group (1991) Low-molecular-weight-heparin (enoxaparin) vs dextran 70. The prevention of post operative deep vein thrombosis after total hip replacement. Arch Intern Med 151: 1621-4
37. Torholme C, Broeeng L, Jorgensen PS et al (1991) Thromboprophylaxis by low-molecular-weight-heparin in elective hip surgery: a placebo controlled study. J Bone Joint Surg 73-B: 434-8
38. Turpie AG, Bauer KA, Eriksson BI, Lassen MR (2002a) Fondaparinux compared with enoxaparin in major orthopaedic surgery: a meta-analysis of 4 randomized trials. Arch Intern Med 162(16): 1806-8
39. Turpie AG, Bauer KA, Eriksson BI, Lassen MR (2002b) Postoperative fondaparinux versus postoperative enoxaparin for the prevention of venous thromboembolism after elective hip replacement surgery: a randomized double blind trial. Lancet 359: 1721-6
40. Warwick DJ, Williams M, Bannister GC (1995) Death and thromboembolic disease after total hip replacement: a series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg (Br) 77-B: 6-10
41. Warwick D, Harrison J, Glew D et al (1998) Comparison of the use of a foot pump with the use of low molecular weight heparin for the prevention of deep venous thrombosis after total hip replacement. J Bone Joint Surg 80: 1158-66
42. Wells PS, Lensing AWA, Hirsh J (1994) Graded compression stockings in the prevention of post operative venous thromboembolism. Arch Intern Med 154: 67-72
43. White RH, Gettner S, Newman JM et al (2000) Predictors of rehospitalization for symptomatic venous thromboembolism after total hip replacement. N Engl J Med 343: 1758-64